IL-10-producing regulatory B cells (B10 cells), IL-17 + T cells and autoantibodies in systemic sclerosis

Clinical Immunology

Volumn 184, Issue , 2017, Pages 26-32

  Mavropoulos, Athanasios ^a   Liaskos, Christos ^a   Simopoulou, Theodora ^a   Bogdanos, Dimitrios P ^a   Sakkas, Lazaros I ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Autoantibody; Autoimmunity; B regulatory cells; Scleroderma; T cells

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BOSENTAN; CD3 ANTIGEN; CEN AUTOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; TOPO I AUTOANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; DNA TOPOISOMERASE; IFNG PROTEIN, HUMAN; IL10 PROTEIN, HUMAN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CD3+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REGULATORY B LYMPHOCYTE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; CASE CONTROL STUDY; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; B-LYMPHOCYTES, REGULATORY; CASE-CONTROL STUDIES; CD3 COMPLEX; DNA TOPOISOMERASES, TYPE I; FEMALE; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-17; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; T-LYMPHOCYTES; YOUNG ADULT;

EID: 85019261317     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2017.04.013     Document Type: Article

References (37)

1. van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis., 72, 2013, 1747.
2. Walker, U.A., Tyndall, A., Czirjak, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann. Rheum. Dis., 66, 2007, 754.
3. Sakkas, L.I., Platsoucas, C.D., Is systemic sclerosis an antigen-driven T cell disease?. Arthritis Rheum., 50, 2004, 1721.
4. Sakkas, L.I., Bogdanos, D.P., Systemic sclerosis: new evidence re-enforces the role of B cells. Autoimmun. Rev., 15, 2016, 155.
5. Sakkas, L.I., Chikanza, I.C., Platsoucas, C.D., Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat. Clin. Pract. Rheumatol., 2, 2006, 679.
6. Okamoto, Y., Hasegawa, M., Matsushita, T., Hamaguchi, Y., Huu, D.L., Iwakura, Y., et al. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum., 64, 2012, 3726.
7. Rosser, E.C., Mauri, C., Regulatory B cells: origin, phenotype, and function. Immunity, 42, 2015, 607.
8. Bouaziz, J.D., Le Buanec, H., Saussine, A., Bensussan, A., Bagot, M., IL-10 producing regulatory B cells in mice and humans: state of the art. Curr. Mol. Med., 12, 2012, 519.
9. Carter, N.A., Rosser, E.C., Mauri, C., Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis. Res. Ther., 14, 2012, R32.
10. Watanabe, R., Ishiura, N., Nakashima, H., Kuwano, Y., Okochi, H., Tamaki, K., et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J. Immunol., 184, 2010, 4801.
11. Tedder, T.F., B10 cells: a functionally defined regulatory B cell subset. J. Immunol., 194, 2015, 1395.
12. Kalampokis, I., Yoshizaki, A., Tedder, T.F., IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis. Res. Ther.(15 Suppl 1), 2013, S1.
13. Daien, C.I., Gailhac, S., Mura, T., Audo, R., Combe, B., Hahne, M., et al. Regulatory B10 cells are decreased in patients with rheumatoid arthritis and are inversely correlated with disease activity. Arthritis Rheum., 66, 2014, 2037.
14. Mavropoulos, A., Simopoulou, T., Varna, A., Liaskos, C., Katsiari, C.G., Bogdanos, D.P., et al. Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheum., 68, 2016, 494.
15. Matsushita, T., Hamaguchi, Y., Hasegawa, M., Takehara, K., Fujimoto, M., Decreased levels of regulatory B cells in patients with systemic sclerosis: association with autoantibody production and disease activity. Rheumatology (Oxford), 55, 2016, 263.
16. Marou, E., Liaskos, C., Efthymiou, G., Dardiotis, E., Daponte, A., Scheper, T., et al. Increased immunoreactivity against human cytomegalovirus UL83 in systemic sclerosis. Clin. Exp. Rheumatol., 2017 (PMID: 28240591, Epub ahead of print).
17. Mavropoulos, A., Smyk, D., Rigopoulou, E.I., Bogdanos, D.P., Human peripheral blood mononuclear cell culture for flow cytometric analysis of phosphorylated mitogen-activated protein kinases. Methods Mol. Biol., 806, 2012, 275.
18. Aybar, L.T., McGregor, J.G., Hogan, S.L., Hu, Y., Mendoza, C.E., Brant, E.J., et al. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies. Clin. Exp. Immunol., 180, 2015, 178.
19. Sheng, J.R., Quan, S., Soliven, B., CD1d(hi)CD5 + B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis. J. Immunol., 193, 2014, 2669.
20. Iikuni, N., Lourenco, E.V., Hahn, B.H., La Cava, A., Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol., 183, 2009, 1518.
21. Liu, Y., Liu, A., Iikuni, N., Xu, H., Shi, F.D., La Cava, A., Regulatory CD4 + T cells promote B cell anergy in murine lupus. J. Immunol., 192, 2014, 4069.
22. Jang, E., Cho, W.S., Cho, M.L., Park, H.J., Oh, H.J., Kang, S.M., et al. Foxp3 + regulatory T cells control humoral autoimmunity by suppressing the development of long-lived plasma cells. J. Immunol., 186, 2011, 1546.
23. Wilde, B., Thewissen, M., Damoiseaux, J., Knippenberg, S., Hilhorst, M., van Paassen, P., et al. Regulatory B cells in ANCA-associated vasculitis. Ann. Rheum. Dis., 72, 2013, 1416.
24. Mauri, C., Bosma, A., Immune regulatory function of B cells. Annu. Rev. Immunol., 30, 2012, 221.
25. Wilson, M.S., Madala, S.K., Ramalingam, T.R., Gochuico, B.R., Rosas, I.O., Cheever, A.W., et al. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med., 207, 2010, 535.
26. Mi, S., Li, Z., Yang, H.Z., Liu, H., Wang, J.P., Ma, Y.G., et al. Blocking IL-17A promotes the resolution of pulmonary inflammation and fibrosis via TGF-beta1-dependent and -independent mechanisms. J. Immunol., 187, 2011, 3003.
27. Kurasawa, K., Hirose, K., Sano, H., Endo, H., Shinkai, H., Nawata, Y., et al. Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum., 43, 2000, 2455.
28. Xing, X., Yang, J., Yang, X., Wei, Y., Zhu, L., Gao, D., et al. IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway. PLoS One, 8, 2013, e85032.
29. Liu, M., Yang, J., Xing, X., Cui, X., Li, M., Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway. Arthritis. Res. Ther., 16, 2014, 4223.
30. Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med., 183, 1996, 2593.
31. Hwang, S.Y., Kim, J.Y., Kim, K.W., Park, M.K., Moon, Y., Kim, W.U., et al. IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis. Res. Ther., 6, 2004, R120.
32. Blaho, V.A., Buczynski, M.W., Dennis, E.A., Brown, C.R., Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17. J. Immunol., 183, 2009, 5644.
33. Ferretti, E., Di Carlo, E., Ognio, E., Guarnotta, C., Bertoni, F., Corcione, A., et al. Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma. Oncoimmunology, 4, 2015, e1030560.
34. Hsu, H.C., Yang, P., Wang, J., Wu, Q., Myers, R., Chen, J., et al. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol., 9, 2008, 166.
35. Blair, P.A., Norena, L.Y., Flores-Borja, F., Rawlings, D.J., Isenberg, D.A., Ehrenstein, M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity, 32, 2010, 129.
36. Fillatreau, S., Sweenie, C.H., McGeachy, M.J., Gray, D., Anderton, S.M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol., 3, 2002, 944.
37. Flores-Borja, F., Bosma, A., Ng, D., Reddy, V., Ehrenstein, M.R., Isenberg, D.A., et al. CD19 + CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med., 5, 2013, 173ra23.